窦律的药物控制2011指南临床集粹.ppt

* * * * * Savelieva, I. et al. Europace 2008 10:647-665; doi:10.1093/europace/eun130 房颤患者使用 Vernakalant 90分钟内转复窦律的百分率 房性心律失常转复临床研究 (ACTs) I to IV 房颤患者窦律药物控制策略 AHA/ACC/ESC Practice Guidelines for AF, 2006 提问与讨论 * * * * * Raster=Scan13.tif * Raster=Scan07.tif * * * * * * * * * * * * * * Canadian trial of AF * * * * * * Molecular structure of amiodarone, dronedarone, and thyroxine. As compared with amiodarone, in the dronedarone molecule, ethyl groups on the terminal nitrogen are replaced by butyls groups, the iodine moiety is removed, and a methanesulfonyl group has been added to benzofuran ri